project id: TCGA-OV; case submitter id: TCGA-42-2588; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.3; rna integrity number: 8.6; spectrophotometer method: UV Spec; age at index: 61; days to birth: -22377; days to death: 880; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1948; age at diagnosis: 22377; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 287.0; figo stage: Stage IV; icd 10 code: C56.9; last known disease status: not reported; morphology: 8441/3; primary diagnosis: Serous cystadenocarcinoma, NOS; prior malignancy: not reported; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Ovary; synchronous malignancy: Not Reported; tissue or organ of origin: Ovary; tumor grade: Not Reported; year of diagnosis: 2009; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to sample procurement: 0; intermediate dimension: 0.7; longest dimension: 0.9; oct embedded: No; shortest dimension: 0.4; portion submitter id: TCGA-42-2588-01A-01; percent necrosis: 0.0; percent stromal cells: 0.0;